WalterArminBrownMD

PubMed

• Mortality during US FDA clinical trials in patients with diabetes, hypertension, depression and schizophrenia.
  Arif Khan, Kaysee Fahl Mar, Sagarika Gokul, Walter A. Brown> ;World Journal of Biological Psychiatry. 2020 Jan 1
• The conundrum of depression clinical trials: one size does not fit all.
  Arif Khan, Kaysee Fahl Mar, Walter A. Brown> ;International Clinical Psychopharmacology. 2018 Sep 1
• Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016.
  Arif Khan, Kaysee Fahl Mar, Joshua Schilling, Walter A. Brown> ;PLOS ONE. 2018 Feb 28
• Decreased suicide rates in recent antidepressant clinical trials.
  Arif Khan, Kaysee Fahl Mar, Sagarika Gokul, Walter A. Brown> ;Psychopharmacology. 2018 Feb 26
• Magnitude and pattern of placebo response in clinical trials of antiepileptic medications: Data from the Food and Drug Administration 1996-2016.
  Arif Khan, Kaysee Fahl Mar, Joshua Schilling, Walter A. Brown> ;Contemporary Clinical Trials. 2018 Jan 1
• Mortality risk with mirtazapine and estimating suicide risk
  Arif Khan, James Faucett, Walter A. Brown> ;JAMA Psychiatry. 2015 Sep 1
• Reply to Millman and Opler.
  Arif Khan, James Faucett, Walter A. Brown> ;Journal of Psychiatric Research. 2015 Feb 1
• Response to letter from Lipsitz et al.
  Arif Khan, James Faucett, Walter A. Brown> ;Journal of Psychiatric Research. 2014 Oct 1
• Magnitude of change with antidepressants and placebo in antidepressant clinical trials using structured, taped and appraised rater interviews (SIGMA-RAPS) compared to ...
  Arif Khan, James Faucett, Walter A. Brown> ;Psychopharmacology. 2014 Apr 26
• Magnitude of placebo response and response variance in antidepressant clinical trials using structured, taped and appraised rater interviews compared to traditional ra...
  Arif Khan, James Faucett, Walter A. Brown> ;Journal of Psychiatric Research. 2014 Apr 1
• Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder particip...
  Arif Khan, James Faucett, Shaneta Morrison, Walter A. Brown> ;JAMA Psychiatry. 2013 Oct 1
• Efficacy and safety of anti-manic agents in children and adults.
  Arif Khan, James Faucett, Graham J. Emslie, Walter A. Brown> ;Israel Journal of Psychiatry and Related Sciences. 2012 Jan 1
• Is "medication visit" a misnomer? Psychotherapy challenges in 90862.
  Deepika Shaligram, Zamir Nestelbaum, Madeline Pearlmutter, Walter A. Brown> ;Psychiatric Services. 2011 May 1
• Antidepressant–placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity
  Arif Khan, Amritha Bhat, James Faucett, Russell L. Kolts, Walter A. Brown> ;Psychopharmacology. 2011 Apr 1
• Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?
  Arif Khan, Amritha Bhat, Russell L. Kolts, Michael E. Thase, Walter A. Brown> ;CNS Neuroscience & Therapeutics. 2010 Aug 1
• Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder.
  Gordon Parker, Max Fink, Edward Shorter, Michael Alan Taylor, Hagop S. Akiskal, German E. Berrios, Tom G. Bolwig, Walter A. Brown, Bernard J. Carroll, David Healy, Don...> ;American Journal of Psychiatry. 2010 Jul 1
• Are the colors and shapes of current psychotropics designed to maximize the placebo response
  Arif Khan, Eswara Prasad Bomminayuni, Amritha Bhat, James Faucett, Walter A. Brown> ;Psychopharmacology. 2010 May 22
• Our visitor from Vienna.
  Brown, W. A.> ;Medicine and health, Rhode Island. 2010 Mar 25
• Are patients with depression at heightened risk of suicide as they begin to recover
  Vikrant Mittal, Walter A. Brown, Edward Shorter> ;Psychiatric Services. 2009 Mar 1
• The persistence of the placebo response in antidepressant clinical trials
  Arif Khan, Nick Redding, Walter A. Brown> ;Journal of Psychiatric Research. 2008 Aug 1
• Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials.
  Arif Khan, Kelly Schwartz, Chelsea Stern, Nick Redding, Russell L. Kolts, Walter A. Brown, Donald S. Robinson> ;The Journal of Clinical Psychiatry. 2007 Dec 14
• Psychiatric Diagnosis and Clinical Trial Completion Rates: Analysis of the FDA SBA Reports
  Arif Khan, Kelly Schwartz, Nick Redding, Russell L. Kolts, Walter A. Brown> ;Neuropsychopharmacology. 2007 Feb 21
• Suicide risk analysis among patients assigned to psychotropics and placebo.
  Arif Khan, Russell L. Kolts, Amy E. Brodhead, K. Ranga Rama Krishnan, Walter A. Brown> ;Psychopharmacology Bulletin. 2006 Jan 1
• Sex differences in antidepressant response in recent antidepressant clinical trials.
  Arif Khan, Amy E. Brodhead, Kelly Schwartz, Russell L. Kolts, Walter A. Brown> ;Journal of Clinical Psychopharmacology. 2005 Aug 1
• Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials
  Arif Khan, Russell L. Kolts, Michael E. Thase, K. Ranga Rama Krishnan, Walter A. Brown> ;American Journal of Psychiatry. 2004 Nov 1
• Join now to see all